Status:
COMPLETED
Efficacy and Tolerability CVI (A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial (CVI)
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Venous Insufficiency
Phase:
PHASE3
Brief Summary
To determine efficacy and tolerability of Antistax 360 mg tablets in chronic venous insufficiency linked to edema (swelling) and subjective symptoms
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT00292435
Start Date
March 1 2006
Last Update
October 29 2013
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
LKH Graz
Graz, Austria
2
AKH Wien
Vienna, Austria
3
VENEX Venenexperten
Vienna, Austria
4
Boehringer Ingelheim Investigational Site
Brno, Czechia